Genomic Health Inc
(GHDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 83,979 | 82,742 | 82,258 | 81,974 | 80,894 |
| Cost of Goods | 13,672 | 13,652 | 13,425 | 15,598 | 16,153 |
| Gross Profit | 70,307 | 69,090 | 68,833 | 66,376 | 64,741 |
| Operating Expenses | 73,804 | 68,250 | 72,277 | 72,072 | 73,701 |
| Operating Income | -2,825 | 1,492 | -3,019 | -5,098 | -8,807 |
| Interest Expense | 0 | 0 | 0 | 0 | -87 |
| Other Income | 3,060 | 777 | 6 | 613 | 1,411 |
| Pre-tax Income | 235 | 2,269 | -3,013 | -4,485 | -7,309 |
| Income Tax | 1,041 | 917 | -193 | 1,615 | -958 |
| Net Income Continuous | -806 | 1,352 | -2,820 | -6,100 | -6,351 |
| Net Income | $-806 | $1,352 | $-2,820 | $-6,100 | $-6,351 |
| EPS Basic Total Ops | -0.02 | 0.03 | -0.08 | -0.18 | -0.19 |
| EPS Basic Continuous Ops | -0.02 | 0.04 | -0.08 | -0.18 | -0.19 |
| EPS Diluted Total Ops | -0.02 | 0.03 | -0.08 | -0.18 | -0.19 |
| EPS Diluted Continuous Ops | -0.02 | 0.04 | -0.08 | -0.18 | -0.19 |
| EBITDA(a) | $-418 | $3,771 | $-730 | $-2,912 | $-6,628 |